Stati Uniti - inglese - NLM (National Library of Medicine)

orchidpharma inc - zaleplon (unii: s62u433rmh) (zaleplon - unii:s62u433rmh) - zaleplon capsules are indicated for the short-term treatment of insomnia. zaleplon capsules have been shown to decrease the time to sleep onset for up to 30 days in controlled clinical studies (see clinical trials under clinical pharmacology ). it has not been shown to increase total sleep time or decrease the number of awakenings. the clinical trials performed in support of efficacy ranged from a single night to 5 weeks in duration. the final formal assessments of sleep latency were performed at the end of treatment. zaleplon is contraindicated in patients: - who have experienced complex sleep behaviors after taking zaleplon (see warnings ). - with hypersensitivity to zaleplon or any excipients in the formulation (see precautions ). zaleplon is classified as a schedule iv controlled substance by federal regulation. abuse and addiction are separate and distinct from physical dependence and tolerance. abuse is characterized by misuse of the drug for non-medical purposes, often in combination with other psychoa

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

fannin limited - modafinil - tablet - 100 milligram(s) - centrally acting sympathomimetics; modafinil

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

fannin limited - modafinil - tablet - 200 milligram(s) - centrally acting sympathomimetics; modafinil

Stati Uniti - inglese - NLM (National Library of Medicine)

orchid healthcare (a division of orchid chemicals & pharmaceuticals ltd.) - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 37.5 mg - venlafaxine hydrochloride extended-release capsules is indicated for the treatment of major depressive disorder. the efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8- and 12-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii-r or dsm-iv category of major depressive disorder (see clinical trials ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessne

Stati Uniti - inglese - NLM (National Library of Medicine)

orchid chemicals & pharmaceuticals limited - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine 5 mg - memantine hydrochloride is indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. controlled substance class: memantine hcl is not a controlled substance. physical and psychological dependence: memantine hcl is a low to moderate affinity uncompetitive nmda antagonist that did not produce any evidence of drug-seeking behavior or withdrawal symptoms upon discontinuation in 2,504 patients who participated in clinical trials at therapeutic doses. post marketing data, outside the u.s., retrospectively collected, has provided no evidence of drug abuse or dependence.

Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

orchidia pharmaceutical industries, egypt - dorzolamide,timolol maleate - eye drops - 2,0.5 %,

Sudafrica - inglese - South African Health Products Regulatory Authority (SAHPRA)

watson pharma no. 1 (pty) ltd - suspension - each 5,0 ml suspension contains cefpodoxime proxetil equivalent to cefpodoxime 40,0 mg

Sudafrica - inglese - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - injection - see ingredients - each 20,0 ml vial contains cefuroxime sodium equivalent to cefuroxime 750,0 mg

Nigeria - inglese - NAFDAC (National Agency for Food and Drugs Administration and Control)

cinnamomum cassia (bark) 65mg, piper longum (fruit) 65mg, adhastoda, vasica (leaf)65mg, glycyrrhiza plabra, 60mg, etc

Nigeria - inglese - NAFDAC (National Agency for Food and Drugs Administration and Control)

holorrhoena antidysenterica 144mg, terminalia chebula 144mg, arsh kuthar rasa 144mg, etc.